Overview on Human Breast Cancer with Focus on Prognostic and Predictive Factors with Special Attention on the Tumour Suppressor Gene P53
Torbjörn Norberg(Uppsala University), Jonas Bergh(Karolinska Institutet), Henrik Lindman(Uppsala University), Christoffer Mårtensson(Uppsala University), T. Jansson(Uppsala University Hospital), Hans Nordgren(Uppsala University Hospital), S. Sjoügren(Uppsala University), M-L. Fjaüllskog(Uppsala University), Lars Holmberg(Uppsala University), A. Lindgren(Wallenberg Wood Science Center), I. Andréasson(Uppsala University)
Cited by 22
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k